Intersect Capital’s Quest Diagnostics DGX Stock Holding History
Bought
Maintained
Sold
Other funds holding DGX
DSA
Intersect Capital's DGX Position: Q2 2022 in Review
Intersect Capital increased its Quest Diagnostics (DGX) stake by 52% in Q2 2022, buying an estimated $204K and bringing the position to 4,376 shares worth $582K. The position accounts for 0.18% of the portfolio, ranked #119.
Intersect Capital first reported a position in DGX in Q4 2014 and has held it in 5 quarters since. 850 funds tracked by Wall St. Rank hold DGX as of Q2 2022.
- Intersect Capital held 4,376 shares of Quest Diagnostics worth $582K as of Q2 2022.
- Intersect Capital bought 1,496 Quest Diagnostics shares in Q2 2022, an estimated $204K.
- Quest Diagnostics made up 0.18% of Intersect Capital's portfolio in Q2 2022, its #119 holding.
- Intersect Capital first reported a position in Quest Diagnostics in Q4 2014 and has held it in 5 quarters since.
- 850 funds tracked by Wall St. Rank held Quest Diagnostics as of Q2 2022.
Based on Intersect Capital's 13F filing for Q2 2022, filed 2 Sep 2022.